Avidity Biosciences Inc. (RNA) NASDAQ
$22.73 (0.31) (-1.34%)
Market Cap: $1.81B
As of 04/19/24 04:00 PM EDT. Market closed.
Avidity Biosciences Inc. (RNA)
NASDAQ
$22.73
(0.31) (-1.34%)
Market Cap: $1.81B
As of 04/19/24 04:00 PM EDT. Market closed.
avidity biosciences is pioneering a new class of precision medicines – antibody-sirna conjugates (asc™) – to deliver nucleic acid therapeutics against genetic drivers of disease. our ascs have drug-like properties similar to antibodies and antibody-drug conjugates. importantly, their unique sirna-based “payloads” permit selective targeting of disease-associated mrnas against virtually ... read more
avidity biosciences is pioneering a new class of precision medicines – antibody-sirna conjugates (asc™) – to deliver nucleic acid therapeutics against genetic drivers of disease. our ascs have drug-like properties similar to antibodies and antibody-drug conjugates. importantly, their unique sirna-based “payloads” permit selective targeting of disease-associated mrnas against virtually any target of interest. our leadership includes seasoned scientists and executives with deep expertise in the fields of antibody conjugation, chemistry, formulations, oligonucleotide therapeutics, drug delivery and cancer biology. our employees are high energy, creative people who are passionate about solving hard problems and bringing new drugs to patients. we strive to work with partners to discover best-in-class molecules with the goal of long-term, joint value creation. we have also attracted support from top-tier investors including f-prime capital, ecor1 capital, brace pharma and other sophisticated read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
LEVIN ARTHUR A | Director | Apr 03, 2024 | Sale | $27.11 | 20,000 | 542,214 | 253,872 | Apr 03, 2024, 08:26 PM |
Boyce Sarah | President and CEO | Apr 02, 2024 | Option Exercise | $1.24 | 28,000 | 34,720 | 140,117 | Apr 03, 2024, 06:16 PM |
Boyce Sarah | President and CEO | Apr 02, 2024 | Sale | $26.25 | 28,000 | 734,919 | 112,117 | Apr 03, 2024, 06:16 PM |
LEVIN ARTHUR A | Director | Mar 19, 2024 | Option Exercise | $1.24 | 5,000 | 6,200 | 19,830 | Mar 21, 2024, 04:10 PM |
LEVIN ARTHUR A | Director | Mar 19, 2024 | Sale | $23.97 | 5,000 | 119,847 | 14,830 | Mar 21, 2024, 04:10 PM |
MacLean Michael F | Chief Financial Officer | Mar 13, 2024 | Option Exercise | $8.82 | 40,000 | 352,800 | 84,093 | Mar 15, 2024, 04:12 PM |
MacLean Michael F | Chief Financial Officer | Mar 13, 2024 | Sale | $24.52 | 40,000 | 980,760 | 44,093 | Mar 15, 2024, 04:12 PM |
LEVIN ARTHUR A | Director | Mar 12, 2024 | Option Exercise | $1.24 | 25,000 | 31,000 | 42,471 | Mar 12, 2024, 08:41 PM |
LEVIN ARTHUR A | Director | Mar 12, 2024 | Sale | $22.03 | 27,641 | 609,017 | 17,471 | Mar 12, 2024, 08:41 PM |
Boyce Sarah | President and CEO | Mar 12, 2024 | Option Exercise | $1.24 | 28,000 | 34,720 | 140,117 | Mar 12, 2024, 05:29 PM |
Boyce Sarah | President and CEO | Mar 08, 2024 | Option Exercise | $1.24 | 84,000 | 104,160 | 196,117 | Mar 12, 2024, 05:29 PM |
Boyce Sarah | President and CEO | Mar 12, 2024 | Sale | $22.63 | 28,000 | 633,682 | 112,117 | Mar 12, 2024, 05:29 PM |
Boyce Sarah | President and CEO | Mar 08, 2024 | Sale | $21.39 | 84,000 | 1,796,710 | 112,117 | Mar 12, 2024, 05:29 PM |
Boyce Sarah | President and CEO | Mar 01, 2024 | Option Exercise | $1.24 | 84,000 | 104,160 | 196,117 | Mar 05, 2024, 04:53 PM |
Boyce Sarah | President and CEO | Mar 01, 2024 | Sale | $20.13 | 84,000 | 1,691,306 | 112,117 | Mar 05, 2024, 04:53 PM |
LEVIN ARTHUR A | Director | Jan 22, 2024 | Sale | $10.13 | 1,859 | 18,832 | 17,471 | Jan 23, 2024, 03:14 PM |
Boyce Sarah | President and CEO | Jan 22, 2024 | Sale | $10.13 | 5,092 | 51,582 | 44,008 | Jan 23, 2024, 03:13 PM |
Flanagan W. Michael | CSTO | Jan 22, 2024 | Sale | $10.13 | 4,129 | 41,827 | 35,871 | Jan 23, 2024, 03:12 PM |
McCarthy Teresa | Chief Human Resources Officer | Jan 22, 2024 | Sale | $10.13 | 2,065 | 20,918 | 17,035 | Jan 23, 2024, 03:11 PM |
MacLean Michael F | Chief Financial Officer | Jan 22, 2024 | Sale | $10.13 | 1,616 | 16,370 | 16,884 | Jan 23, 2024, 03:11 PM |
LEVIN ARTHUR A | Director | Mar 15, 2023 | Option Exercise | $1.24 | 100 | 124 | 19,430 | Mar 17, 2023, 04:36 PM |
LEVIN ARTHUR A | Director | Mar 15, 2023 | Sale | $22.01 | 100 | 2,201 | 19,330 | Mar 17, 2023, 04:36 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Feb 14, 2023 | Option Exercise | $1.24 | 10,000 | 12,400 | 29,330 | Feb 15, 2023, 08:30 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Feb 14, 2023 | Sale | $23.66 | 10,000 | 236,567 | 19,853 | Feb 15, 2023, 08:30 PM |
Boyce Sarah | President and CEO | Feb 03, 2023 | Option Exercise | $1.24 | 3,221 | 3,994 | 56,573 | Feb 03, 2023, 05:26 PM |
Boyce Sarah | President and CEO | Feb 02, 2023 | Option Exercise | $1.24 | 45,879 | 56,890 | 99,231 | Feb 03, 2023, 05:26 PM |
Boyce Sarah | President and CEO | Feb 01, 2023 | Option Exercise | $1.24 | 900 | 1,116 | 54,252 | Feb 03, 2023, 05:26 PM |
Boyce Sarah | President and CEO | Feb 02, 2023 | Sale | $24.36 | 45,879 | 1,117,741 | 53,352 | Feb 03, 2023, 05:26 PM |
Boyce Sarah | President and CEO | Feb 01, 2023 | Sale | $24.27 | 900 | 21,844 | 53,352 | Feb 03, 2023, 05:26 PM |
Boyce Sarah | President and CEO | Feb 03, 2023 | Sale | $24.26 | 3,221 | 78,141 | 53,352 | Feb 03, 2023, 05:26 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jan 12, 2023 | Option Exercise | $1.24 | 10,000 | 12,400 | 11,330 | Jan 17, 2023, 08:50 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jan 12, 2023 | Sale | $22.00 | 10,000 | 220,028 | 1,330 | Jan 17, 2023, 08:50 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Dec 29, 2022 | Option Exercise | $1.24 | 40,000 | 49,600 | 41,330 | Jan 03, 2023, 05:40 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Dec 29, 2022 | Sale | $22.01 | 40,000 | 880,568 | 1,330 | Jan 03, 2023, 05:40 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 12, 2022 | Option Exercise | $0.53 | 14,003 | 7,422 | 15,333 | Aug 31, 2022, 08:08 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 16, 2022 | Option Exercise | $1.24 | 3,499 | 4,339 | 4,829 | Aug 31, 2022, 08:08 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 15, 2022 | Option Exercise | $0.92 | 62,498 | 57,802 | 63,828 | Aug 31, 2022, 08:08 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 12, 2022 | Sale | $22.00 | 14,003 | 308,066 | 1,330 | Aug 31, 2022, 08:08 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 16, 2022 | Sale | $22.08 | 3,499 | 77,257 | 1,330 | Aug 31, 2022, 08:08 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 15, 2022 | Sale | $22.12 | 62,498 | 1,382,343 | 1,330 | Aug 31, 2022, 08:08 PM |
Boyce Sarah | President and CEO | Aug 25, 2022 | Option Exercise | $1.24 | 14,855 | 18,420 | 14,855 | Aug 26, 2022, 07:29 PM |
Boyce Sarah | President and CEO | Aug 24, 2022 | Option Exercise | $1.24 | 35,045 | 43,456 | 35,045 | Aug 26, 2022, 07:29 PM |
Boyce Sarah | President and CEO | Aug 25, 2022 | Sale | $23.07 | 14,855 | 342,690 | 0 | Aug 26, 2022, 07:29 PM |
Boyce Sarah | President and CEO | Aug 24, 2022 | Sale | $22.80 | 35,045 | 798,924 | 0 | Aug 26, 2022, 07:29 PM |
Boyce Sarah | President and CEO | Aug 15, 2022 | Option Exercise | $1.24 | 100 | 124 | 100 | Aug 17, 2022, 09:40 PM |
Boyce Sarah | President and CEO | Aug 15, 2022 | Sale | $22.47 | 100 | 2,247 | 0 | Aug 17, 2022, 09:40 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Nov 18, 2021 | Option Exercise | $1.22 | 25,000 | 30,571 | 26,330 | Nov 22, 2021, 08:22 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Nov 18, 2021 | Sale | $27.89 | 25,000 | 697,218 | 1,330 | Nov 22, 2021, 08:22 PM |
RTW INVESTMENTS, LP | 10% Owner | Aug 04, 2021 | Buy | $18.00 | 800,000 | 14,400,000 | 4,795,000 | Aug 06, 2021, 11:20 AM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 24, 2021 | Option Exercise | $1.24 | 100 | 124 | 1,430 | Jun 28, 2021, 07:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 25, 2021 | Option Exercise | $1.13 | 20,100 | 22,735 | 21,430 | Jun 28, 2021, 07:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 24, 2021 | Sale | $27.75 | 100 | 2,775 | 1,330 | Jun 28, 2021, 07:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 25, 2021 | Sale | $28.12 | 20,100 | 565,299 | 3,977 | Jun 28, 2021, 07:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 17, 2021 | Option Exercise | $1.24 | 200 | 248 | 1,530 | Jun 22, 2021, 08:24 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 17, 2021 | Sale | $27.75 | 200 | 5,550 | 1,330 | Jun 22, 2021, 08:24 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 15, 2021 | Sale | $26.02 | 23,019 | 599,067 | 0 | Jun 16, 2021, 08:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 14, 2021 | Sale | $25.92 | 14,003 | 362,921 | 23,019 | Jun 16, 2021, 08:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Mar 16, 2021 | Option Exercise | $0.94 | 4,600 | 4,302 | 4,600 | Mar 18, 2021, 09:39 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Mar 16, 2021 | Sale | $27.87 | 4,600 | 128,181 | 0 | Mar 18, 2021, 09:39 PM |
Cormorant Asset Management, LP | Former 10% Owner | Jun 16, 2020 | Buy | $18.00 | 300,000 | 5,400,000 | 2,514,545 | Jun 18, 2020, 04:02 PM |
RTW INVESTMENTS, LP | 10% Owner | Jun 16, 2020 | Buy | $18.00 | 950,000 | 17,100,000 | 3,995,000 | Jun 16, 2020, 04:28 PM |
Owner | Relationship | Date | Value($) |
LEVIN ARTHUR A | Director | 04/03/2024 | 542,214 |
Boyce Sarah | President and CEO | 04/02/2024 | 34,720 |
Boyce Sarah | President and CEO | 04/02/2024 | 734,919 |
LEVIN ARTHUR A | Director | 03/19/2024 | 6,200 |
LEVIN ARTHUR A | Director | 03/19/2024 | 119,847 |
MacLean Michael F | Chief Financial Officer | 03/13/2024 | 352,800 |
MacLean Michael F | Chief Financial Officer | 03/13/2024 | 980,760 |
LEVIN ARTHUR A | Director | 03/12/2024 | 31,000 |
LEVIN ARTHUR A | Director | 03/12/2024 | 609,017 |
Boyce Sarah | President and CEO | 03/12/2024 | 34,720 |
Boyce Sarah | President and CEO | 03/08/2024 | 104,160 |
Boyce Sarah | President and CEO | 03/12/2024 | 633,682 |
Boyce Sarah | President and CEO | 03/08/2024 | 1,796,710 |
Boyce Sarah | President and CEO | 03/01/2024 | 104,160 |
Boyce Sarah | President and CEO | 03/01/2024 | 1,691,306 |
LEVIN ARTHUR A | Director | 01/22/2024 | 18,832 |
Boyce Sarah | President and CEO | 01/22/2024 | 51,582 |
Flanagan W. Michael | CSTO | 01/22/2024 | 41,827 |
McCarthy Teresa | Chief Human Resources Officer | 01/22/2024 | 20,918 |
MacLean Michael F | Chief Financial Officer | 01/22/2024 | 16,370 |
LEVIN ARTHUR A | Director | 03/15/2023 | 124 |
LEVIN ARTHUR A | Director | 03/15/2023 | 2,201 |
LEVIN ARTHUR A | Chief Scientific Officer | 02/14/2023 | 12,400 |
LEVIN ARTHUR A | Chief Scientific Officer | 02/14/2023 | 236,567 |
Boyce Sarah | President and CEO | 02/03/2023 | 3,994 |
Boyce Sarah | President and CEO | 02/02/2023 | 56,890 |
Boyce Sarah | President and CEO | 02/01/2023 | 1,116 |
Boyce Sarah | President and CEO | 02/02/2023 | 1,117,741 |
Boyce Sarah | President and CEO | 02/01/2023 | 21,844 |
Boyce Sarah | President and CEO | 02/03/2023 | 78,141 |
LEVIN ARTHUR A | Chief Scientific Officer | 01/12/2023 | 12,400 |
LEVIN ARTHUR A | Chief Scientific Officer | 01/12/2023 | 220,028 |
LEVIN ARTHUR A | Chief Scientific Officer | 12/29/2022 | 49,600 |
LEVIN ARTHUR A | Chief Scientific Officer | 12/29/2022 | 880,568 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/12/2022 | 7,422 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/16/2022 | 4,339 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/15/2022 | 57,802 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/12/2022 | 308,066 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/16/2022 | 77,257 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/15/2022 | 1,382,343 |
Boyce Sarah | President and CEO | 08/25/2022 | 18,420 |
Boyce Sarah | President and CEO | 08/24/2022 | 43,456 |
Boyce Sarah | President and CEO | 08/25/2022 | 342,690 |
Boyce Sarah | President and CEO | 08/24/2022 | 798,924 |
Boyce Sarah | President and CEO | 08/15/2022 | 124 |
Boyce Sarah | President and CEO | 08/15/2022 | 2,247 |
LEVIN ARTHUR A | Chief Scientific Officer | 11/18/2021 | 30,571 |
LEVIN ARTHUR A | Chief Scientific Officer | 11/18/2021 | 697,218 |
RTW INVESTMENTS, LP | 10% Owner | 08/04/2021 | 14,400,000 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/24/2021 | 124 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/25/2021 | 22,735 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/24/2021 | 2,775 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/25/2021 | 565,299 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/17/2021 | 248 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/17/2021 | 5,550 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/15/2021 | 599,067 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/14/2021 | 362,921 |
LEVIN ARTHUR A | Chief Scientific Officer | 03/16/2021 | 4,302 |
LEVIN ARTHUR A | Chief Scientific Officer | 03/16/2021 | 128,181 |
Cormorant Asset Management, LP | Former 10% Owner | 06/16/2020 | 5,400,000 |
RTW INVESTMENTS, LP | 10% Owner | 06/16/2020 | 17,100,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 6,496,593 | 0.0015% | 12.27% | Other |
RA CAPITAL MANAGEMENT, L.P. | 2,454,533 | 0.35% | -61.75% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,600,000 | 0.03% | 23.08% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,547,214 | 0.00147% | 7.78% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 1,215,837 | 0.02% | -39.81% | Event Driven |
CANDRIAM S.C.A. | 290,067 | 0.02% | 70.56% | Other |
RENAISSANCE TECHNOLOGIES LLC | 226,700 | 0.00318% | 104.6% | Other |
ALPS ADVISORS INC | 50,673 | 0.00361% | -7.41% | Other |
D. E. SHAW & CO., INC. | 41,486 | 0.00033% | -72.93% | Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,708 | 0.00313% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View